• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺相关病毒8型结合蛋白2(AAV8BP2)和腺相关病毒8型(AAV8)能高效转导哺乳动物的耳蜗外侧壁和内淋巴囊。

AAV8BP2 and AAV8 transduce the mammalian cochlear lateral wall and endolymphatic sac with high efficiency.

作者信息

Isgrig Kevin, Ishibashi Yasuko, Lee Hyun Jae, Zhu Jianliang, Grati Mhamed, Bennett Jean, Griffith Andrew J, Roux Isabelle, Chien Wade W

机构信息

Inner Ear Gene Therapy Program, National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health, Bethesda, MD, USA.

Otolaryngology Branch, NIDCD, National Institutes of Health, Bethesda, MD, USA.

出版信息

Mol Ther Methods Clin Dev. 2022 Jul 31;26:371-383. doi: 10.1016/j.omtm.2022.07.013. eCollection 2022 Sep 8.

DOI:10.1016/j.omtm.2022.07.013
PMID:36034771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9386391/
Abstract

Inner ear gene therapy using adeno-associated viruses (AAVs) has been successfully applied to several mouse models of hereditary hearing loss to improve their auditory function. While most inner ear gene therapy studies have focused on the mechanosensory hair cells and supporting cells in the organ of Corti, the cochlear lateral wall and the endolymphatic sac have not garnered much attention. The cochlear lateral wall and the endolymphatic sac play critical roles in inner ear ionic and fluid homeostasis. Mutations in genes expressed in the cochlear lateral wall and the endolymphatic sac are present in a large percentage of patients with hereditary hearing loss. In this study, we examine the transduction patterns and efficiencies of conventional (AAV2 and AAV8) and synthetic (AAV2.7m8, AAV8BP2, and Anc80L65) AAVs in the mouse inner ear. We found that AAV8BP2 and AAV8 are capable of transducing the marginal cells and intermediate cells in the stria vascularis. These two AAVs can also transduce the epithelial cells of the endolymphatic sac. Our data suggest that AAV8BP2 and AAV8 are highly useful viral vectors for gene therapy studies targeting the cochlear lateral wall and the endolymphatic sac.

摘要

使用腺相关病毒(AAV)的内耳基因疗法已成功应用于多种遗传性听力损失小鼠模型,以改善其听觉功能。虽然大多数内耳基因治疗研究都集中在柯蒂氏器中的机械感觉毛细胞和支持细胞上,但耳蜗外侧壁和内淋巴囊并未受到太多关注。耳蜗外侧壁和内淋巴囊在内耳离子和液体稳态中起关键作用。在很大比例的遗传性听力损失患者中,耳蜗外侧壁和内淋巴囊中表达的基因存在突变。在本研究中,我们研究了传统型(AAV2和AAV8)和合成型(AAV2.7m8、AAV8BP2和Anc80L65)AAV在小鼠内耳中的转导模式和效率。我们发现AAV8BP2和AAV8能够转导血管纹中的边缘细胞和中间细胞。这两种AAV还可以转导内淋巴囊的上皮细胞。我们的数据表明,AAV8BP2和AAV8是针对耳蜗外侧壁和内淋巴囊的基因治疗研究中非常有用的病毒载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/51653d2ad15f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/56274f63877e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/45355eb27cf9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/6f9c44b90c90/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/e37aa90496a0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/696e8e1e452a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/12c36d239a75/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/bd9ea7ccdb6d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/51653d2ad15f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/56274f63877e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/45355eb27cf9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/6f9c44b90c90/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/e37aa90496a0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/696e8e1e452a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/12c36d239a75/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/bd9ea7ccdb6d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/9386391/51653d2ad15f/gr7.jpg

相似文献

1
AAV8BP2 and AAV8 transduce the mammalian cochlear lateral wall and endolymphatic sac with high efficiency.腺相关病毒8型结合蛋白2(AAV8BP2)和腺相关病毒8型(AAV8)能高效转导哺乳动物的耳蜗外侧壁和内淋巴囊。
Mol Ther Methods Clin Dev. 2022 Jul 31;26:371-383. doi: 10.1016/j.omtm.2022.07.013. eCollection 2022 Sep 8.
2
AAV2.7m8 is a powerful viral vector for inner ear gene therapy.AAV2.7m8 是内耳基因治疗的有力病毒载体。
Nat Commun. 2019 Jan 25;10(1):427. doi: 10.1038/s41467-018-08243-1.
3
Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness.联合 AAV 介导的基因替代疗法改善人类 DFNB42 耳聋小鼠模型的听觉功能。
Mol Ther. 2023 Sep 6;31(9):2783-2795. doi: 10.1016/j.ymthe.2023.07.014. Epub 2023 Jul 22.
4
Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac.腺病毒载体接种内淋巴囊后内耳转基因表达。
Hum Gene Ther. 1999 Mar 20;10(5):769-74. doi: 10.1089/10430349950018526.
5
Stria vascularis and cochlear hair cell changes in syphilis: A human temporal bone study.梅毒中血管纹和耳蜗毛细胞的变化:一项人类颞骨研究。
Auris Nasus Larynx. 2016 Dec;43(6):614-9. doi: 10.1016/j.anl.2016.01.001. Epub 2016 Feb 6.
6
Expression of transient receptor potential vanilloid (TRPV) 1, 2, 3, and 4 in mouse inner ear.瞬时受体电位香草酸亚型(TRPV)1、2、3和4在小鼠内耳中的表达。
Acta Otolaryngol. 2008;128(12):1286-93. doi: 10.1080/00016480801938958.
7
Inner ear immunity.内耳免疫。
Hear Res. 2022 Jun;419:108518. doi: 10.1016/j.heares.2022.108518. Epub 2022 May 11.
8
Expression pattern of aquaporin water channels in the inner ear of the rat. The molecular basis for a water regulation system in the endolymphatic sac.水通道蛋白在大鼠内耳中的表达模式。内淋巴囊水调节系统的分子基础。
Hear Res. 1999 Jun;132(1-2):76-84. doi: 10.1016/s0378-5955(99)00036-2.
9
Inner ear hemorrhage and endolymphatic hydrops in a leukemic patient with sudden hearing loss.一名白血病患者突发听力丧失伴内耳出血和内淋巴积水
Ann Otol Rhinol Laryngol. 1977 Jul-Aug;86(4 Pt 1):518-24. doi: 10.1177/000348947708600412.
10
Efficient in Utero Gene Transfer to the Mammalian Inner Ears by the Synthetic Adeno-Associated Viral Vector Anc80L65.合成腺相关病毒载体Anc80L65在子宫内高效地将基因转移至哺乳动物内耳。
Mol Ther Methods Clin Dev. 2020 Jun 24;18:493-500. doi: 10.1016/j.omtm.2020.06.019. eCollection 2020 Sep 11.

引用本文的文献

1
Exploring AAV-Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential.探索腺相关病毒介导的内耳疾病基因治疗:从临床前成功到临床潜力
Adv Sci (Weinh). 2025 Sep;12(33):e08397. doi: 10.1002/advs.202408397. Epub 2025 Jun 20.
2
SLC26A4-AP-2 mu2 interaction regulates SLC26A4 plasma membrane abundance in the endolymphatic sac.SLC26A4-AP-2 mu2 相互作用调节内淋巴囊中 SLC26A4 的质膜丰度。
Sci Adv. 2024 Oct 11;10(41):eadm8663. doi: 10.1126/sciadv.adm8663. Epub 2024 Oct 9.
3
Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness.

本文引用的文献

1
Single-Cell RNA-Seq of Cisplatin-Treated Adult Stria Vascularis Identifies Cell Type-Specific Regulatory Networks and Novel Therapeutic Gene Targets.顺铂处理的成年血管纹的单细胞RNA测序确定了细胞类型特异性调控网络和新型治疗基因靶点。
Front Mol Neurosci. 2021 Sep 9;14:718241. doi: 10.3389/fnmol.2021.718241. eCollection 2021.
2
Dissection of the Endolymphatic Sac from Mice.从老鼠中解剖内淋巴管囊。
J Vis Exp. 2021 Mar 29(169). doi: 10.3791/62375.
3
Gene therapy via canalostomy approach preserves auditory and vestibular functions in a mouse model of Jervell and Lange-Nielsen syndrome type 2.
联合 AAV 介导的基因替代疗法改善人类 DFNB42 耳聋小鼠模型的听觉功能。
Mol Ther. 2023 Sep 6;31(9):2783-2795. doi: 10.1016/j.ymthe.2023.07.014. Epub 2023 Jul 22.
4
Advances in cochlear gene therapies.耳蜗基因治疗的进展。
Curr Opin Pediatr. 2023 Dec 1;35(6):631-640. doi: 10.1097/MOP.0000000000001273. Epub 2023 Jul 6.
经壶腹造瘘途径的基因治疗可保留 Jervell 和 Lange-Nielsen 综合征 2 型小鼠模型的听觉和前庭功能。
Nat Commun. 2021 Jan 29;12(1):697. doi: 10.1038/s41467-020-20808-7.
4
Genome and base editing for genetic hearing loss.基因组和碱基编辑治疗遗传性听力损失。
Hear Res. 2020 Sep 1;394:107958. doi: 10.1016/j.heares.2020.107958. Epub 2020 Apr 5.
5
Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges.腺相关病毒基因替代治疗隐性内耳功能障碍:进展与挑战。
Hear Res. 2020 Sep 1;394:107947. doi: 10.1016/j.heares.2020.107947. Epub 2020 Mar 18.
6
Disease mechanisms and gene therapy for Usher syndrome.Usher 综合征的发病机制与基因治疗。
Hear Res. 2020 Sep 1;394:107932. doi: 10.1016/j.heares.2020.107932. Epub 2020 Mar 4.
7
Forgotten Fibrocytes: A Neglected, Supporting Cell Type of the Cochlea With the Potential to be an Alternative Therapeutic Target in Hearing Loss.被遗忘的纤维细胞:一种被忽视的耳蜗支持细胞类型,有望成为听力损失的替代治疗靶点。
Front Cell Neurosci. 2019 Dec 6;13:532. doi: 10.3389/fncel.2019.00532. eCollection 2019.
8
Gene therapy for hereditary hearing loss by SLC26A4 mutations in mice reveals distinct functional roles of pendrin in normal hearing.基因治疗小鼠 SLC26A4 突变所致遗传性听力损失揭示了 Pendrin 在正常听力中的不同功能作用。
Theranostics. 2019 Sep 23;9(24):7184-7199. doi: 10.7150/thno.38032. eCollection 2019.
9
Age-dependent alterations of Kir4.1 expression in neural crest-derived cells of the mouse and human cochlea.年龄依赖性改变在小鼠和人类耳蜗神经嵴衍生细胞 Kir4.1 表达。
Neurobiol Aging. 2019 Aug;80:210-222. doi: 10.1016/j.neurobiolaging.2019.04.009. Epub 2019 Apr 18.
10
Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model.双 AAV 介导的基因治疗恢复 DFNB9 小鼠模型的听力。
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4496-4501. doi: 10.1073/pnas.1817537116. Epub 2019 Feb 19.